Us Fda Clears Jubilant Therapeutics Ind For Novel Dual Lsd1 & Hdac6 Inhibitor Jbi-802 For Treatment Of Solid Tumours

Jubilant Therapeutics Inc, A Biopharmaceutical Company, Announced Us Food And Drug Administration (Fda) Clearance Of The Investigational New Drug Application (Ind) For Jbi-802, A Novel, Oral, Potent And Selective Dual Inhibitor Of Lsd1 And Hdac6, For The Treatment Of Small Cell Lung Cancer (Sclc), Treatment-Induced Neuro-Endocrine Prostate Cancer (Nepc) And Other Mutation-Defined Neuroendocrine Tumours.The Phase 1/2A Trial Is An Open-Label, Two-Part Dose Escalation And Expansion Study Designed To Define The Safety Profile And Preliminary Activity Of Jbi-802 In Participants With Advanced Solid Tumours. The Study Population Will Include Patients With Locally Advanced Or Metastatic Solid Tumours Whose Disease Has Failed Prior Standard Therapy. Expansion Cohorts Of Participants With Sclc, Nepc, And Other Neuroendocrine-Derived Cancers Will Be Enrolled To Obtain Additional Safety And Efficacy Data.Hari S Bhartia, Chairman, Jubilant Therapeutics Said

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!